Cat. #151139
Anti-CD44 [P2A1]
Cat. #: 151139
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: CD44
Class: Monoclonal
Application: FACS ; IHC ; IF ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: John Marshall
Institute: Queen Mary University of London
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD44 [P2A1]
- Alternate name: CD44 Molecule; Hematopoietic Cell E- And L-Selectin Ligand; GP9 Lymphocyte Homing/Adhesion Receptor; Chondroitin Sulfate Proteoglycan 8; Extracellular Matrix Receptor III; Heparan Sulfate Proteoglycan; Phagocytic Glycoprotein; Hyaluronate Receptor; Hermes Antigen; ECMR-III; HUTCH-I; Epican; CDW44; MDU2; MDU3; MIC4; LHR; Cell Surface Glycoprotein CD44; Phagocytic Glycoprotein I; Soluble CD44; CSPG8; HCELL; PGP-1; MC56; Pgp1
- Research fields: Cell biology;Cancer;Cell signaling and signal transduction;Immunology
- Clone: P2A1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 95 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IF ; IP
- Description: CD44 is a broadly distributed receptor that binds hyaluronan. CD44 splice variants are associated with metastasis.
- Immunogen: Ocular melanoma cell line (V+B2)
- Isotype: IgG2a
- Myeloma used: P3/NS1/1-Ag4.1
Target Details
- Target: CD44
- Molecular weight: 95 kDa
- Target background: CD44 is a broadly distributed receptor that binds hyaluronan. CD44 splice variants are associated with metastasis.
Applications
- Application: FACS ; IHC ; IF ; IP
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- The Interplay of Antigen Affinity, Internalization, and Pharmacokinetics on CD44-Positive Tumor Targeting of Monoclonal Antibodies.
- Glatt et al. 2016. Mol Pharm. :. PMID: 27079967.
- Bains et al. 2002. Fertil Steril. 78(2):307-12. PMID: 12137867.
- Human sperm cells express CD44.
- Nath et al. 1999. Immunology. 98(2):213-9. PMID: 10610356.
- Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin.
